Tag: Novartis
Novartis launches Innovation Prize to support the multiple sclerosis community
Applications are now open for The Novartis Innovation Prize: Assistive Tech for Multiple Sclerosis (MS) which identifies and embraces technology that aims to improve mobility...
CSL completes acquisition of Novartis flu division
Australian pharmaceutical giant CSL has completed the US $275 million acquisition of Novartis' influenza business.
The transaction will see CSL combine the influenza vaccines division with its...
CSL acquires Novartis flu division
CSL is set to become the second largest flu vaccine business in the world with the acquisition of a subsidiary of Swiss pharmaceutical multinational...
Novartis, GSK shake up pharmaceutical industry with major deals
Pharmaceutical giant Novartis and global healthcare company GlaxoSmithKline (GSK) have announced a series of transactions worth billions of dollars that will transform both firms'...
Featured Article
Data-rich or data-poor: Where should manufacturers focus their AI efforts?
Over the past year, manufacturers worldwide have made significant strides in adopting artificial intelligence technologies, moving beyond the initial hype to tangible implementations that deliver real business value.
